Search Results

CLARITY Analysis Studies Factors Affecting Midterm Results of Endovascular Treatment of Ruptured Intracranial Aneurysms

October 1, 2012—In the American Journal of Neuroradiology, Laurent Pierot, MD, et al published an analysis of the factors affecting the midterm anatomic results after endovascular treatment of ruptured intracranial aneurysms in the large multicenter series, CLARITY (Clinical and Anatomic Results in the Treatment of Ruptured Intracranial Aneurysms) (2012;33:1475–1480).

Sequent Medical Announces 1-Year Data and Launches Next-Generation Web Intracranial Aneurysm Embolization System

May 12, 2015—Sequent Medical, Inc. announced that prospective long-term clinical data for the company’s Web aneurysm embolization system were presented by Prof.

Neurointerventional Societies Outline New Criteria for Stroke Centers

September 7, 2018—The Society of NeuroInterventional Surgery (SNIS), with 12 other international neurointerventional societies, have released new guidelines outlining the criteria for level 1, 2, and 3 stroke centers that provide acute ischemic stroke interventions.

Sequent Medical's WEBCAST Study Presented at ESMINT

September 8, 2014—Sequent Medical, Inc. announced the presentation of results from WEBCAST, a prospective study of the company’s Web aneurysm embolization system, at ESMINT, the European Society of Minimally Invasive Neurological Therapy Congress in Nice, France.

Data Support Sequent Medical's Web Aneurysm Embolization System

November 14, 2013—Sequent Medical, Inc. (Aliso Viejo, CA) announced the presentation of long-term results from a retrospective study of the company’s Web aneurysm embolization system at the World Federation of Interventional Neuroradiology Congress in Buenos Aires, Argentina.

Neuravi Introduces Collaborative Clot Research Initiative at ESMINT

September 5, 2014—Neuravi, an Ireland-based developer of innovative stroke therapy, announced the Neuravi Thromboembolic Initiative (NTI).

CE Mark Granted for Sequent Medical's Web SL Family of Neurovascular Aneurysm Embolization Devices

May 20, 2013—Sequent Medical, Inc. (Aliso Viejo, CA) announced that it has received CE Mark approval for the SL (single-layer) family of Web aneurysm embolization devices and has commenced a controlled release of these new models in select neurovascular centers in Europe.